HL7 Stability Standard Implementation Guide Teleconference Minutes 2016-05-02
HL7 Stability Standard Teleconference Minutes
May 2, 2016
Attendees: Norman Gregory (CVM), Catherine Hosage-Norman (Module 3 Solutions, LLC), Mike Mlodzik (Boehringer Ingelheim Vetmedica, Inc.), Matthew Battaglia (Merial), Tammy Wright (Dechra), Michele Cobham (Par/ENDO Pharmaceutical), James Murphy (Par/ENDO ER Pharmaceutical), and Hardy Oh (Par/ENDO Pharmaceutical)
- The following announcement was posted on the FDA web page, FDA Resources for Data Standard:
On July 9, 2012, the President signed into law the Food and Drug Administration Safety and Innovation Act (FDASIA) (Public Law 112-144). FDASIA enables FDA to require standardized, fully electronic submissions for certain applications in an effort to facilitate FDA’s review. To that end, the Agency is evaluating the use of electronic data exchange standards for receiving stability and other quality (chemistry, manufacturing and controls) data in eCTD submissions. Also, we are investigating the efficiencies of standardizing other pharmaceutical quality data. FDA is assessing the current HL7 eStability standard. The HL7 Version 3 Implementation Guide: Drug Stability Reporting (eStability) R2, Release 3, published in February 2012, provides technical conformance criteria for eStability files based on some of the same business rules and vocabularies used by the drug establishment, registration and listing process at the FDA. The eStability R2 version implements, in electronic form, a model that is currently used for submission of stability data in paper and eCTD format. FDA is also considering the feasibility of HL7’s FHIR technology for possible future use. The Study Data Standards page (http://www.fda.gov/ForIndustry/DataStandards/StudyDataStandards/default.htm) points to the Stability Data Standards page (http://www.fda.gov/ForIndustry/DataStandards/StabilityDataStandard/default.htm) where the announcement is posted.
- The re-affirmation ballot of the eStability message will take place at the MAY HL7 Working Group Meeting. Balloting closes to today and it appears to have meet quorum and passed.
- There will be no teleconference 5/9/16.
Agenda for May 16, 2016 Teleconference:
- Outstanding issues
- The phone number is 770-657-9270 and the participation code is 7485962 and we will be a new WebEx link.
Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.